Market Price

10.80 

0.00 0.0%

as of Jul 16 '19

52 Week Range:

9.82 12.58


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

SOL S.p.A. engages in the applied research, production, and distribution of industrial gases, pure and medicinal gases, and in door-to-door medical care and related medical equipment in Italy and internationally. It offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous helium, as well as synthetic and compressed air; gases and gas mixtures for respiratory and therapeutic, and diagnostic and instrumental use; and special gases and gas mixtures. The company also provides services, apparatus, and products for home oxygen therapy, home mechanical ventilation, home artificial feeding, and home treatment of bed sores; home treatment services for nocturnal apnoea syndrome; and integrated homecare services. In addition, it produces hydroelectric power; and engages in the exploration and identification, design, construction, and running of hydroelectric power stations connected to the national high tension distribution network. Further, the company designs, constructs, and manages bio banks, cell factories, and centers for processing and conserving cells and tissues; offers pre-and post-natal diagnostic services; and produces and sells diagnostic systems and services. Additionally, it is involved in the GMP production of monoclonal antibodies and recombinant proteins; and scientific, pre-clinical, and clinical research of biological pharmaceuticals, as well as the provision of transport and biological sample conservation services for third parties. SOL S.p.A. products are used in the chemical, electronics, iron and steel, engineering, and foodstuff industries, as well as in environmental protection and research and health sectors. The company was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. is a subsidiary of Gas and Technologies World BV.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 3.34
3.52
3.78
4.02
4.15
4.23
growth rate 5.4% 7.4% 6.4% 3.2% 1.9%
Earnings BIT 42.74
43.10
52.50
49.77
46.51
49.96
58.09
61.54
75.30
68.82
85.63
growth rate 0.8% 21.8% -5.2% -6.6% 7.4% 16.3% 5.9% 22.4% -8.6% 24.4%
Avg.PE 7.17
14.35
14.01
11.95
12.50
23.87
24.43
23.34
26.13
23.70
20.73
growth rate 100.1% -2.4% -14.7% 4.6% 91.0% 2.4% -4.5% 12.0% -9.3% -12.5%
ROA 6.14
4.12
4.97
4.48
3.87
2.76
growth rate -32.9% 20.6% -9.9% -13.6% -28.7%
ROE 12.03
8.06
9.63
8.81
7.82
5.68
growth rate -33.0% 19.5% -8.5% -11.2% -27.4%
ROIC 12.95
8.17
10.46
10.60
4.84
5.60
growth rate -36.9% 28.0% 1.3% -54.3% 15.7%
Cur. Ratio 2.11
2.18
2.17
2.23
2.58
2.42
growth rate 3.3% -0.5% 2.8% 15.7% -6.2%
Quick Ratio 1.75
1.85
1.84
0.31
2.16
2.04
growth rate 5.7% -0.5% -83.2% 596.8% -5.6%
Leverage 1.96
1.95
1.92
2.01
2.03
2.09
growth rate -0.5% -1.5% 4.7% 1.0% 3.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 192.00
200.70
238.00
270.00
262.00
262.22
252.47
272.84
280.77
291.04
307.53
growth rate 4.5% 18.6% 13.5% -3.0% 0.1% -3.7% 8.1% 2.9% 3.7% 5.7%
Acct.Payable 69.00
86.00
75.00
77.20
83.45
88.96
91.43
105.49
107.34
growth rate 24.6% -12.8% 2.9% 8.1% 6.6% 2.8% 15.4% 1.8%
Cur.Assets 271.90
285.00
304.00
353.00
361.00
368.72
389.39
422.77
452.86
462.72
493.82
growth rate 4.8% 6.7% 16.1% 2.3% 2.1% 5.6% 8.6% 7.1% 2.2% 6.7%
Total Assets 592.90
624.20
659.00
732.00
769.00
799.68
880.13
960.49
1,015.73
1,059.99
1,112.15
growth rate 5.3% 5.6% 11.1% 5.1% 4.0% 10.1% 9.1% 5.8% 4.4% 4.9%
Cash 33.30
42.00
32.00
48.00
61.00
67.32
95.67
101.99
119.67
117.18
129.35
growth rate 26.1% -23.8% 50.0% 27.1% 10.4% 42.1% 6.6% 17.3% -2.1% 10.4%
Inventory 26.70
28.50
32.00
32.00
33.00
33.34
35.09
39.02
40.92
46.45
50.70
growth rate 6.7% 12.3% 0.0% 3.1% 1.0% 5.2% 11.2% 4.9% 13.5% 9.2%
Cur.Liabilities 128.20
131.00
140.00
158.00
140.00
152.22
164.14
182.75
170.31
200.44
214.20
growth rate 2.2% 6.9% 12.9% -11.4% 8.7% 7.8% 11.3% -6.8% 17.7% 6.9%
Liabilities 280.40
304.70
305.00
356.00
381.00
403.61
458.26
502.36
526.30
554.10
566.15
growth rate 8.7% 0.1% 16.7% 7.0% 5.9% 13.5% 9.6% 4.8% 5.3% 2.2%
LT Debt 0.00
0.00
151.00
183.00
221.00
232.30
271.98
298.13
331.02
329.98
327.25
growth rate 21.2% 20.8% 5.1% 17.1% 9.6% 11.0% -0.3% -0.8%
Equity 312.50
329.60
353.90
375.40
388.30
383.50
408.55
442.98
472.05
490.31
527.94
growth rate 5.5% 7.4% 6.1% 3.4% -1.2% 6.5% 8.4% 6.6% 3.9% 7.7%
Common Shares 91.00
91.00
90.70
90.70
90.70
47.16
47.16
47.16
47.16
47.16
47.16
growth rate 0.0% -0.3% 0.0% 0.0% -48.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 73.30
62.40
62.00
85.00
85.00
91.76
96.65
84.72
98.38
93.72
94.70
growth rate -14.9% -0.6% 37.1% 0.0% 8.0% 5.3% -12.3% 16.1% -4.7% 1.0%
Cash Dividends 7.30
7.30
7.60
8.60
9.10
9.34
9.46
9.98
10.88
13.61
13.61
growth rate 0.0% 4.1% 13.2% 5.8% 2.6% 1.3% 5.5% 9.1% 25.0% 0.0%
Cash From OA 65.50
80.40
62.00
86.00
87.00
99.70
124.51
92.70
117.96
136.71
132.61
growth rate 22.8% -22.9% 38.7% 1.2% 14.6% 24.9% -25.6% 27.3% 15.9% -3.0%
FCF per Share -0.11
0.15
-0.05
-0.02
-0.04
0.04
growth rate 100.0% -100.0% 0.0% 0.0% 100.0%
FCF -10.00
13.00
-4.00
-2.00
-3.00
5.00
27.87
7.97
19.58
42.99
37.91
growth rate 100.0% -100.0% 0.0% 0.0% 100.0% 457.3% -71.4% 145.6% 119.5% -11.8%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 460.00
479.10
534.00
567.00
593.00
606.16
650.76
689.33
714.85
768.44
845.41
growth rate 4.2% 11.5% 6.2% 4.6% 2.2% 7.4% 5.9% 3.7% 7.5% 10.0%
Op.Income 51.50
49.90
33.00
32.00
30.00
49.96
58.09
61.54
75.30
68.82
85.63
growth rate -3.1% -33.9% -3.0% -6.3% 66.5% 16.3% 5.9% 22.4% -8.6% 24.4%
IBT 42.70
43.10
52.50
49.80
46.50
45.16
51.43
56.06
69.80
66.86
81.17
growth rate 0.9% 21.8% -5.1% -6.6% -2.9% 13.9% 9.0% 24.5% -4.2% 21.4%
Net Income 36.00
26.10
33.00
32.00
30.00
21.63
29.18
32.44
44.13
40.24
51.88
growth rate -27.5% 26.4% -3.0% -6.3% -27.9% 34.9% 11.2% 36.0% -8.8% 28.9%
EPS 0.38
0.28
0.35
0.34
0.32
0.24
growth rate -26.3% 25.0% -2.9% -5.9% -25.0%
Gross Profit 180.20
194.40
123.00
126.00
126.00
127.99
138.93
144.19
161.54
159.25
179.47
growth rate 7.9% -36.7% 2.4% 0.0% 1.6% 8.5% 3.8% 12.0% -1.4% 12.7%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 18.40
22.71
22.71
20.11
20.11
growth rate 23.4% 0.0% -11.4% 0.0%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 291.04
307.42
307.42
307.53
307.53
growth rate 5.6% 0.0% 0.0% 0.0%
Acct.Payable 105.49
111.23
111.23
107.34
107.34
growth rate 5.4% 0.0% -3.5% 0.0%
Cur.Assets 462.72
493.72
493.72
493.82
493.82
growth rate 6.7% 0.0% 0.0% 0.0%
Total Assets 1,059.99
1,112.59
1,112.59
1,112.15
1,112.15
growth rate 5.0% 0.0% 0.0% 0.0%
Cash 117.18
126.01
126.01
129.35
129.35
growth rate 7.5% 0.0% 2.7% 0.0%
Inventory 46.45
49.38
49.38
50.70
50.70
growth rate 6.3% 0.0% 2.7% 0.0%
Cur.Liabilities 200.44
220.30
220.30
214.20
214.20
growth rate 9.9% 0.0% -2.8% 0.0%
Liabilities 554.10
591.41
591.41
566.15
566.15
growth rate 6.7% 0.0% -4.3% 0.0%
LT Debt 329.98
347.16
347.16
327.25
327.25
growth rate 5.2% 0.0% -5.7% 0.0%
Equity 490.31
503.84
503.84
527.94
527.94
growth rate 2.8% 0.0% 4.8% 0.0%
Common Shares 47.16
47.16
47.16
47.16
47.16
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 22.98
25.35
25.35
22.00
22.00
growth rate 10.3% 0.0% -13.2% 0.0%
Cash Dividends 6.80
6.80
6.80
growth rate 0.0% 0.0%
Cash From OA 41.83
30.30
30.30
36.00
36.00
growth rate -27.6% 0.0% 18.8% 0.0%
FCF 18.86
4.95
4.95
14.00
14.00
growth rate -73.7% 0.0% 182.6% 0.0%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 196.30
208.82
208.82
213.89
213.89
growth rate 6.4% 0.0% 2.4% 0.0%
Op.Income 18.40
22.71
22.71
20.11
20.11
growth rate 23.4% 0.0% -11.4% 0.0%
IBT 18.59
21.33
21.33
19.26
19.26
growth rate 14.7% 0.0% -9.7% 0.0%
Net Income 11.65
13.92
13.92
12.02
12.02
growth rate 19.4% 0.0% -13.6% 0.0%
EPS
growth rate
Gross Profit 41.41
45.49
45.49
44.25
44.25
growth rate 9.8% 0.0% -2.7% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (34.24)

YOY Growth Grade:

E (32.61)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 19.06 18.88 21.80
EPS / Growth 25.2% 0.57

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 5.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 5.9% 15.5% 15.5%
Future PE 11.76 23.98 23.98
Future EPS 1.01 2.43 2.43
Value Price
MOS %
2.94
-72.7%
14.37
33.1%
14.37
33.1%
MOS Price 1.47 7.19 7.19
IRT 12.54 8.74 8.74

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.